Breathe Well Live Well
|
Asthma Therapeutics Market to 2019 : Global Industry Analysis, Size, Share …
SBWire (press release) Albany, NY — (SBWIRE) — 10/09/2013 — Asthma Market to 2019”. The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. |
View full post on asthma – Google News
|
Asthma Therapeutics Market to 2019 – Breakthrough Biologics to Enhance …
SBWire (press release) The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This growth is expected despite the generic erosion facing … |
View full post on asthma – Google News
|
New Market Research Report: EpiCast Report: Asthma – Epidemiology Forecast …
SBWire (press release) Boston, MA — (SBWIRE) — 07/06/2013 — Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma (GINA) report … |
View full post on asthma – Google News
|
Global asthma market to reach 159 million lifetime cases by 2022
The Pharma Letter Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion. While drugs to manage asthma have existed for several decades, pharmaceutical companies have developed faster acting and more effective products over … |
View full post on asthma – Google News
|
The First Real Cure in the $25 billion Asthma Market?
NBCNews.com Everyone has had a friend at school who was asthmatic. Life is not easy for the chronic asthmatic. It is painful experience watching kids wheezing and groaning under an attack on the playground, looking for their inhalers. A number of therapies … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: CHF1535 pMDI + AC Plus; Drug: BDP and Formoterol + AC Plus
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Completed – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Glenmark Generics recalls anti-asthma drug from US market
NDTV Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on "off-odour" complaints, according to US Food and Drug Administration. Montelukast Sodium … |
View full post on asthma – Google News
 Hindu Business Line |
Glenmark Generics recalls anti-asthma drug from US market
Hindu Business Line Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on “off-odour” complaints, according to US Food and Drug Administration. Montelukast Sodium … |
View full post on asthma – Google News
 Economic Times |
Glenmark Generics recalls anti-asthma drug from US market
Economic Times HYDERABAD: Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on "off-odour" complaints, according to US Food and Drug Administration. |
View full post on asthma – Google News
|
Global Preventive Asthma Drugs Market 2011-2015 New Report
SBWire (press release) Naperville, IL — (SBWIRE) — 12/28/2012 — Global Preventive Asthma Drugs market to grow at a CAGR of 4.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing incidence of asthma. The Global … |
View full post on asthma – Google News